Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluation of the impact of neutralizing antibodies on IFNβ response.
Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
High Intensity Exercise in Multiple Sclerosis: Effects on Muscle Contractile Characteristics and Exercise Capacity, a Randomised Controlled Trial.
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
[One case of pediatric multiple sclerosis with convulsions as initial symptoms].
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Auditory function in children with Charcot-Marie-Tooth disease.
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
Alemtuzumab for the treatment of multiple sclerosis.
Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Purinergic signalling in the urinary tract in health and disease.
Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis.
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's disease.
Vitamin d and multiple sclerosis: correlation, causality, and controversy.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Metabolite Changes in Normal Appearing Cervical Spinal Cord in Two Patients with Multiple Sclerosis. A Proton MR Spectroscopic Analysis.
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care.
A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
Pages
« first
‹ previous
…
664
665
666
667
668
669
670
671
672
…
next ›
last »